Catalyst: A Biopharmaceutical Company Focused on Rare Diseases

Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.

Catalyst Pharmaceuticals, Inc.

A look ahead at go-to-market innovation in rare diseases - Putnam

Rachel Johnson on LinkedIn: Catalyst: A Biopharmaceutical Company

Catalyst Pharmaceuticals, Inc. on LinkedIn: Welcome! You are

Dan Brennan on LinkedIn: Do your part to make September Brain

The Power of Being Counted – RARE-X

Clinical Accelerator announces collaboration with Deerfield

Catalyst Pharmaceuticals, Inc. on LinkedIn: Rare Disease Day 2023

Dan Brennan on LinkedIn: Catalyst: A Biopharmaceutical Company

Catalyst Pharmaceuticals, Inc. on LinkedIn: Four key strategies

Life Science and Healthcare — Avalon